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B20 antigenCaenorhabditis elegans embryonic elongation depends on both epidermal and muscle cells. The hemidesmo-
some-like junctions, commonly called ﬁbrous organelles (FOs), that attach the epidermis to the extracellular
matrix ensure muscle anchoring to the cuticular exoskeleton and play an essential role during elongation.
To further deﬁne how hemidesmosomes might control elongation, we searched for factors interacting with the
core hemidesmosome component, the spectraplakinhomologVAB-10.Using theVAB-10plakindomain as bait in
a yeast two-hybrid screen,we identiﬁed thenovel proteinT17H7.4.Wealso identiﬁedT17H7.4 inan independent
bioinformatic search for essential nematode-speciﬁc proteins that could deﬁne novel anti-nematode drug or
vaccine targets. Interestingly, T17H7.4 corresponds to theC. elegansequivalent of theparasiticOvB20 antigen, and
has a characteristic hemidesmosome distribution.We identiﬁed twomutations in T17H7.4, one of which deﬁnes
the uncharacterized gene pat-12, previously identiﬁed in screens for genes required for muscle assembly. Using
isoform-speciﬁc GFP constructs, we showed that one pat-12 isoform with a hemidesmosome distribution can
rescue a pat-12 null allele. We further found that lack of pat-12 affects hemidesmosome integrity, with marked
defects at the apical membrane. PAT-12 deﬁnes a novel component of C. elegans hemidesmosomes, which is
required for maintaining their integrity. We suggest that PAT-12 helps maintaining VAB-10 attachment with
matrix receptors.m), lmichel@igbmc.fr
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The elongation of tissues plays a critical role in the morphogenesis
and organogenesis ofmany species (Keller, 2006). It generally involves a
combination of junction and cytoskeleton remodelling to drive cell
shape changes, and can additionally require directed cell division, cell
growth, or external forces to favour extension in a certain direction
(Butler et al., 2009; Lecuit and Le Goff, 2007). Embryonicmorphogenesis
has been mainly examined in tissues involving a single cell type (i.e.,
Drosophila germband or trachea, vertebrate notochord). However it can
also involvemultiple tissues thatmust then interactwith each other. The
mechanisms that control such cell–cell interactions duringmorphogen-
esis remain poorly understood.Caenorhabditis elegans provides an elegant model to study this
issue. During C. elegans embryonic morphogenesis, the embryo
elongates four-fold along the anterior-posterior axis in the absence
of cell division or cell migration (Priess and Hirsh, 1986). This elon-
gation process depends on three epidermal cell groups (dorsal,
ventral and seam) (Chisholm and Hardin, 2005), as well as on muscle
cells, which are in contact with the dorsal and ventral epidermal cells,
but not with the seam cells (Chisholm andHardin, 2005;Williams and
Waterston, 1994). Embryonic elongation requires intact adherens
junctions between epithelial cells, and ﬁbrous organelles (FOs). The
latter structure has two roles; it acts like a trans-epithelial tendon,
transmitting the force of movement from the muscles to the
exoskeleton, and it strengthens the epidermis, rendering it resistant
to shearing stress (Zhang and Labouesse, 2010). The contribution of
FOs to morphogenesis, and their interplay with cellular processes
driving cell shape changes, remain a poorly understood aspect of
C. elegans morphogenesis.
FOs consist of two hemidesmosome-like junctions connected by
cytoplasmic intermediate ﬁlaments (cIFs), which mediate epidermal
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epidermis from muscles (Fig. 1A) (Francis and Waterston, 1991). The
C. elegans hemidesmosome-like junctions (abbreviated below CeHD)
are structurally, molecularly and functionally related to vertebrate
hemidesmosomes (Zhang and Labouesse, 2010). They include, as in
vertebrates, a Plectin/BPAG1e homologue (VAB-10A), and cIFs (IFB-1,
MUA-6 and IFA-3) (Fig. 1A) (Bosher et al., 2003;Hapiaket al., 2003;Woo
et al., 2004). They differ, however, in the transmembrane receptors
linking plakin to the extracellular matrix (see Fig. 1A). Absence of most
FO proteins leads to FO partial disassembly, and to a loss of epidermal
integrity, such that the epidermis expands along the apico-basal axis or
detaches from the cuticle and muscles (Bosher et al., 2003; Ding et al.,
2003, 2008; Hapiak et al., 2003; Hresko et al., 1999; Woo et al., 2004).
Embryos with defective FOs do not elongate beyond the two-fold stage
and contain muscles that collapse centrally within the epidermis. The
molecular basis for abnormal elongation in CeHDmutantsmight extend
beyond the epidermal integrity problem. Indeed, their actin cytoskel-
eton, which is essential for elongation, displays some anchoring andFig. 1. Identiﬁcation of T17H7.4 in a search for potential anti-nematode targets. (A) Sche
hemidesmosomes. The main differences between them are the presumptive transmembran
MUP-4 apically) or FNIII (LET-805 basally) repeats, versus the α6ß4-integrin in vertebrates
Kank) and a probable VAB-19 interactor similar to the signalling adaptor protein Eps-8 (Din
and O. volvulus B20 protein identity. Black and grey boxes represent 50% identity and 20% id
FOs (scale bar, 10 μm). (D–E) Polarized light pictures on wild-type (D) and T17H7.4 (RNAi
50 μm). (F-G) DIC pictures of wild-type (F) and T17H7.4(RNAi) treated animals (G). Scale bbundling defects (Bosher et al., 2003; Ding et al., 2003). Moreover, a
recent analysis suggested that hemidesmosome remodelling is coupled
to actin remodelling (Zahreddine et al., 2010). Although these data
indicate that CeHDs and the actin remodelling machinery might be
interdependent, the nature of this link has not yet been deﬁned.
A deeper understanding of the control of elongation by hemidesmo-
somes requires knowledge of all the components of CeHDs. Here we
report the characterization of pat-12, which we identiﬁed as a novel
CeHD component using two parallel and independent strategies.
Speciﬁcally, one of us (C.B.) was interested in deﬁning genes that
could deﬁnenovel anti-nematodedrug or vaccine targets. In the process
of screening for such genes, we became interested in a gene that was
later identiﬁed as pat-12. The other group (M.L.) identiﬁed the same
gene in a yeast two-hybrid screen using as bait the core CeHD
component VAB-10A. We describe the expression pattern of the many
different pat-12 isoforms and show that one of them is located in
epidermal CeHD. Lack of this isoform speciﬁcally affects intermediate
ﬁlament organization and apical membrane organization.matic comparison between C. elegans ﬁbrous organelles (left) and vertebrate (right)
e receptors: nematode-speciﬁc transmembrane domain proteins with EGF (MUA-3 and
. Additional CeHD components include the Ankyrin-repeat protein VAB-19 (similar to
g et al., 2003, 2008). Cut, cuticle; Epid, epidermis; Mus, muscle. (B) C. elegans T17H7.4A
entity, respectively. (C) OvB20 antibody staining on an adult wild-type N2 focusing on
) adults (E) showing muscle detachment (arrow) in RNAi-treated animals (scale bars,
ars: 50 μm (C–D), 10 μm (E–F).
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C. elegans culture and strains
Control N2 and other strains were grown on NGM plates seeded with
OP50Escherichia coliat 20 °Cunless otherwise stated (Brenner, 1974). The
following alleles were used: pat-12(st430) and pat-12(tm2298), which
were outcrossed seven times against N2 and maintained in trans to the
balancer sC1(s2023)[dpy-1(s2170)]; vab-10(h1356); vab-10A(e698); as
well as the strains EE86 mup-4(mg36) III;mupIS1[mup-4::GFP; pRF4 (rol-
6)] andML1050 mcIs44[lin-26p::vab-10ABD::mcherry, myo-2p-GFP] IV.
RNA interference (RNAi)
RNAi by feeding was carried out on NGM plates supplemented with
1mM IPTG and 100 μg/ml carbenicillin, using clones from the Ahringer-
MRC library (Kamathet al., 2003). AnRNAi feedingvector for T17H7.4was
created by amplifying a 925 bp region spanning the 3' end of T17H7.4
coding sequence using the primers 5'-aagaacgtcgtagccgtcat and 5'-
actcttgggttgcttcgttg. The resulting PCR product was cloned into the
plasmid L4440 (Addgene), which was transformed into electro-compe-
tent HT115(DE3) E. coli. RNAi-inducing bacteria were grown overnight at
37 °C and inducedwith 1mMof IPTGbefore being spread onplates.Wild-
type N2 animals were prepared by alkaline hypochlorite treatment of
gravid adults and the resultant L1 larvae were placed on freshly seeded
RNAi plates; phenotypes were recorded 3 and 4 days later. Double
stranded RNA (dsRNA) for injection was generated using the Ambion
mMessage mMachine kit as described elsewhere (Bosher et al., 2003),
and injected into young adults. Injected animals were allowed to recover
overnight, then allowed to lay eggs for 1 h; their semi-synchronized
progeny were examined for phenotypes or stained within the same day.
Yeast two-hybrid screen
We utilized a stringent version of the two-hybrid system that
expresses baits and prey from low copy number plasmids. This system
uses the three reporter genes GAL1::HIS3, GAL1::lacZ and SPAL10::URA3 to
test for an interaction compared with controls, as described (Vidal, 1997;
Walhout and Vidal, 2001). The region encoding VAB-10 residues 408–
1363was cloned into the Gateway® yeast expression vector pPC97-Dest,
as described (Hartley et al., 2000;Walhout et al., 2000). The resulting DB-
ORF plasmid was transformed into the yeast strain Mav203. Auto-
activation was tested by testing the activation of GAL1::HIS3 on minimal
medium lacking histidine but containing 20 mM 3-amino-1,2,4-triazole
(3-AT) in the absence of anyAD-containing vector, as described (Walhout
and Vidal, 2001). The bait strain containing the VAB-10-DB fusion was
transformedwith theC. elegansAD-CecDNA library (Walhout et al., 2000),
as described (Walhout and Vidal, 2001), in order to obtain 1.5 x 106
double transformants. After 4–5 days at 30 °C, single 3-AT resistant
colonies were picked onto synthetic complete medium lacking Leu, Trp,
and His and containing 20 mM 3-AT and then re-arrayed on similar fresh
selective medium. Finally, the VAB-10(408–1363)–GEI-16 interaction
was retested by gap repair in fresh Mav203 containing the VAB-10(408–
1363)–DB fusion, as described (Walhout and Vidal, 2001). To determine
which region of VAB-10A is involved in the interaction with GEI-16, we
generated VAB-10A–DBdeletion plasmids. The following VAB-10A amino
acids corresponding sequences were introduced in pDest32 (Invitrogen)
to generate the different spectrin repeat deletions: Spec1–2 (408–743),
Spec1–3 (408–986), Spec1–5 (408–1218), Spec6 (1211–1363), Spec5–6
(1102–1363), Spec4–6 (980–1363), Spec3–6 (737–1363), Spec1 (408–
632), Spec2 (632–743), Spec3 (746–986). The VAB-10A–DB deletion
plasmids were then individually transformed with a GEI-16A–AD
construct corresponding to the amino acids (30–243) introduced in
pDest22 (Invitrogen). Positive interactions were selected for on minimal
medium lacking Leu, Trp and His but containing 20 mM 3-AT. After 4–5
days growth at 30 °C, single 3-AT resistant colonies were picked and re-arrayed on similar fresh selective medium. In addition, these positive
interactionswere conﬁrmed by testing for the activation of theGAL1::lacZ
and SPAL10::URA3 promoters as described in (Walhout and Vidal, 2001).
Cell cultures, transfections and co-IPs
VAB-10-HA was produced by amplifying the region encoding the
plakindomain (aminoacids530–1363)with a3’primer containing anHA
tag. PAT-12-FLAG was produced by amplifying the region corresponding
to the Y2H clone (see above)with a 3’ primer containing a FLAG tag. Each
PCR product was inserted in the pcDNA3 vector (Invitrogen).
HeLa cells (American Type Culture Collection, Rockville, MD, USA)
were grown in Dulbecco's modiﬁed Eagle's medium (DMEM) supple-
mented with 5% foetal bovine serum and 1% gentamycin. 1.8 x 106 cells
were plated on a six-well plate (300000 cells per well) and maintained
in an incubator at 37 °C with 5% CO2 for 24 h. HeLa cells were then
transfected with 1 μg/well of each plasmid using JetPEI™ reagent from
Polyplus Transfection™, and cultured for 24 h post-transfection. Cells
were then collected in cold 1× PBS and lysed in 300 μl cold lysis buffer
(50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100
supplemented with Protease Inhibitor Cocktail (Roche)) for 15 min on
ice. Cell lysates were centrifuged for 30 min at 14000 rpm at 4 °C. 50 μl
of the supernatant were kept for the input control and supplemented
with 16.6 μl of 4× loading buffer. The remaining 250 μl were added to
the anti-FLAG M2 Afﬁnity Gel (Sigma) and incubated overnight at 4 °C
on a rocking machine. The gel was rinsed three times with lysis buffer
and resuspended in 150 μl of 1× loading buffer. Samples were
electrophoresed on 12.5% SDS–polyacrylamide gels and transferred
onto nitrocellulose membranes. Membranes were blocked for 1 h at
room temperature in blocking buffer (1× PBS, 0.01% Tween-20
containing 3% non-fat milk powder), and then incubated overnight at
4 °Cwith anti-FLAG or anti-HAHRP-conjugated antibodies, both diluted
1:2000 in blocking buffer. Membranes were washed ﬁve times in 1×
PBS/0.01% Tween-20 for 5 min, and resolved by chemi-luminescence
(Immobilon™Western HRP substrate, Millipore).
pat-12/T17H7.4 cDNAs and reporter constructs
cDNAs
T17H7.4 cDNAsweremade by RT-PCR using SuperScript® II Reverse
Transcriptase (Invitrogen) on both mixed stage and embryonic RNA
samples. A common reverse primer was made for all isoforms and
speciﬁc primers were made to all putative ATGs. Subsequently cDNAs
were cloned into pGEM®-T Easy by AT-cloning.
GFP reporters
All reporter constructs were created by PCR with Expand Long
Taq DNA Polymerase (Roche; amplicons greater than 5 kB) or HiFi
PCR (Stratagene; amplicons less than 5 kB). Promoters for tran-
scriptional GFP reporters were created by amplifying genomic DNA
from the cosmid T17H7 with the following primers: construct A, 5'-
accggtctgcaaacccttcctgtagc and 5'-accggtcgtcgaccaatatgttttttgagc;
construct J, 5'-accggtcgagtgcctgcaattgtct and 5'-accggtgctccgagttga-
gaaactttg; construct K, 5'-accggtcaagtttcctgaaaatgctcct and 5'-
accggtgttgcgcctgggattttac. PCR products were inserted at the AgeI
site of the vector pPD95.75 (Addgene). Translational GFP reporters
were created by PCR of promoters (see above) and cDNAs;
promoters were directionally cloned into pPD95.75 with SphI and
KpnI enzymes; cDNAs were placed between promoters and the GFP
coding sequence by digestion with AgeI. The translational GFP
reporter for isoforms E/F/I was created by PCR fusion, using a
promoter PCR product and a GFP PCR product using the primers 5'-
tgcaatacgtccacctgaaa and 5'gagtcgacctgcaggcatgcaagctacgacgacgtc-
tatcatcattcag (promoter and coding sequence), 5'-agcttgcatgcctg-
caggtcgact and 5'-tctgtgcggtatttcacacc (GFP coding sequence and
unc-54 3'UTR from the plasmid pPD95.75). The ﬁnal product was
Fig. 2. Identiﬁcation of T17H7.4 in a search for potential VAB-10A interactors.
(A) Schematic representation of T17H7.4 (upper part; see Fig. 1) showing the position
of the yeast two-hybrid clone identiﬁed in a screen against the plakin domain of VAB-
10A (lower part). This plakin domain contains six spectrin repeats (see part B).
(B) Yeast two-hybrid experiment between different variants of the six plectin domains
of VAB-10A (bait) and a fragment of T17H7.4 (prey; see Fig. 3 for details). The yeast
two-hybrid interaction was tested by evaluating the expression of three different
genes: HIS3, URA3 and LacZ on appropriate media. (C) Co-IP experiment between the
six plectin domains of VAB-10A tagged with an HA tag and a fragment of T17H7.4
(same fragment as used for the yeast two-hybrid screen) tagged with a FLAG tag. The
co-IP was performed using an anti-FLAG antibody. As a control, GFP tagged with a FLAG
tag was used to co-IP VAB-10A.
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cgtacggccgactagtagg.
Transgenic animals
Constructs were injected into N2 young adults at a concentration
of 10 ng/μl with 100ng/μl of the dominant rol-6 containing plasmid
pRF4 [rol-6(su1006)] as an injectionmarker and pBSKII at 90 ng/μl. An
average of 10 lines were examined to select the best lines (most
stable, least mosaic and best signal) which correspond to the
following transgene names for each isoform : mcEx534 for gei-16A,
mcEx537 for gei-16K, mcEx538 for gei-16J and mcEx539 for gei-16E.
Rescue was assayed after injection into pat-12(tm2298)/sC1(s2023)
[dpy-1(s2170)] animals. The gei-16A::GFP transgene generated in the
pat-12 mutant background corresponds to mcEx535.
Scoring lethality and DIC phenotypes
To determine embryonic lethality approximately 20 mothers
were placed on a plate with a fresh and small bacterial spot and
allowed to lay eggs for a few hours. Mothers were removed, embryos
were counted at 8 h and 24 h after egg-laying. When scoring rescue
by transgenes, the proportion of ﬂuorescent embryos or larvae was
also determined 24 h post-laying under a Leica MZIII ﬂuorescence
stereomicroscope. For DIC, animals were mounted in M9 buffer and
examined under a Zeiss Axioplan microscope. In some cases, animals
were also examined under polarized light after anesthetising larvae
with 0.1% sodium azide in M9 buffer.
Immunoﬂuorescence
Embryos and larvae and adults were ﬁxed and stained by indirect
immunoﬂuorescence as described elsewhere (Bosher et al., 2003). The
MH4, MH46 and MH3 monoclonal antibodies (Developmental Studies
Hybridoma Bank, University of Iowa) (Francis and Waterston, 1991)
and the NE8/4C6 mAb (Medical Research Council) (Schnabel, 1995)
were diluted 1:250; the rabbit antisera against VAB-10A (4F2) (Bosher
et al., 2003), and GFP (Roche)were diluted 1:1000. The OvB20 antibody
was the kind gift of Dr.Wang Yu and used at a dilution of 1:100. Primary
antibodies were detected using Cy3- or FITC-conjugated secondary
antibodies. Stacks of images every 0.3 μmwere capturedusinga confocal
microscope (Leica SP2 AOBS/IRBE or Leica MP5 confocal microscope);
approximately 10 confocal sections were projected using image J
software and then processed using Adobe Photoshop®. Hoechst 33258
staining was performed as previously described (Moribe et al., 2004).
Electron microscopy
Embryos and larvae were ﬁxed by High Pressure Freezing using
a Leica Empact2. Freeze substitution was performed in the Leica EM
AFS for 60 h at −90 °C in 2% osmium tetroxide 0.25% uranyl acetate/
0.5% glutaraldehyde/1% H2O in pure acetone. Temperature was raised
to−30 °C at a 3 °C/h rate; samples were incubated for 12 h at−30 °C
in pure acetone, then inﬁltrated in a graded concentration of epon–
araldite resin mix (Sigma). Pictures were acquired using a FEI
Morgagni transmission electron microscope operated at 70 kV.
Results
T17H7.4 identiﬁcation
We identiﬁed T17H7.4 in a bioinformatic search for nematode-
speciﬁc genes (Fig. S1), with a predicted essential function, that could
become novel drug or vaccine targets for treatment of infections with
parasitic nematodes (Behm et al., 2005). The gene T17H7.4 attracted
our attention for two reasons. First, it encodes several isoforms with
strong homology to antigen B20 from the ﬁlarial nematode Oncho-cerca volvulus (Fig. 1B) (Abdel-Wahab et al., 1996), which partially
protects different hosts against infection when used for immunization
(Graham et al., 2000; Taylor et al., 1995). Second, T17H7.4 from
C. elegans was identiﬁed in a yeast two-hybrid screen against the Rac
regulator GEX-3 (Tsuboi et al., 2002) but was not characterized
beyond showing that the gene is probably essential.
To deﬁne at what stage T17H7.4 is essential, we repeated the RNAi
tests performed by Tsuboi and colleagues (Tsuboi et al., 2002). Using
RNAi feeding on young L1 larvae, we found that by the time control
animals had reached the adult moult, 40% of T17H7.4(RNAi) animals
were dead (n=600), oftenwithmoulting problems, and the remainder
were paralysed due to detached muscles (Fig. 1E; Fig. S2B). Further-
more, T17H7.4(RNAi) larvae coulduptakeHoechst dyewithout anyprior
permeabilisation, which is indicative of a defective cuticle (Fig. S2D).
Paralysis combined with moulting defects could mean that this gene
acts in muscles and the epidermis. Alternatively, it could primarily
reﬂect a FO defect in all muscle-cuticle anchoring structures. Consistent
with the latter possibility, an antibody against the OvB20 antigen
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distribution characteristic of CeHDs (Fig. 1C).
To conﬁrm the possibility that T17H7.4 could primarily affect
CeHDs, we injected T17H7.4 dsRNA into young adults to observe
embryonic phenotypes (RNAi-treated larvae produced too few
progeny). We observed that most embryos failed to undergo proper
morphogenesis (95%), and arrested prior to the two-fold stage with
thin head and tail (Fig. 1G), barely moving within the eggshell. This
phenotype is strikingly reminiscent of that observed in mutants
lacking one of the essential CeHD components, such as LET-805, VAB-
10A, VAB-19, EPS-8, IFB-1A, IFA-3 (Bosher et al., 2003; Ding et al.,
2003, 2008; Hapiak et al., 2003; Hresko et al., 1999; Woo et al., 2004).
On the other hand, we independently identiﬁed T17H7.4 in a yeast
two-hybrid screenusing as bait the central VAB-10plakin domain,which
consists of six spectrin repeats (Fig. 2A). Out of 106 colonies screened on
selective medium, we identiﬁed 26 candidate VAB-10 partners, two of
which encoded the N-terminal region of T17H7.4 (Fig. 2A; a full list of
candidates is the focus of another study to be presented elsewhere). We
further reﬁned theVAB-10 region that potentially binds toT17H7.4 to the
ﬁrst and third spectrin domains (Fig. 2B). We also observed that the
T17H7.4 clone recovered in the yeast two-hybrid screen could interact
with itself if T17H7.4–LexA DNA-binding and T17H7.4–GAL4-activation
fusion constructs were co-transformed in yeast (data not shown). To
conﬁrm the VAB-10A–T17H7.4 potential interaction, we expressed the
ﬁrst 243 residues of T17H7.4 tagged with FLAG, and the VAB-10 plakin
domain tagged with HA in HeLa cells, and tested whether we could co-
immuno-precipitate (co-IP) the two proteins. As shown in Fig. 2C, an
antibody against FLAG could immuno-precipitate both VAB-10-HA and
T17H7.4-FLAG, whereas it did not precipitate VAB-10-HA from cells co-
expressing VAB-10-HA and FLAG-GFP.Fig. 3. T17H7.4 corresponds to pat-12. (A) Genetic map and gene organisation of the pat-12/T
encoding the VAB-10B-interacting clone are shown. The cDNAs represented are those we co
exons located beyond themost conserved region of the gene. (B–E) DIC pictures of wild-type
For B, C, D and E, scale bar, 5 μm.Taken together, the biochemical interaction between T17H7.4 and
VAB-10, the subcellular localisation of the OvB20-related antigen and
the phenotype observed after RNAi against T17H7.4 indicate that it
might encode a novel hemidesmosome component.
T17H7.4 corresponds to the gene pat-12
To conﬁrm the phenotype observed after T17H7.4(RNAi), we
examined the phenotype of the deletion allele T17H7.4(tm2298)
recently produced by the National BioResource Project (Japan).
T17H7.4 is a complex gene predicted by Wormbase to generate 27
isoforms,many of whichwe conﬁrmed in our own RT-PCR experiments
(Fig. 3A). The alleleT17H7.4(tm2298) is likely tobe anull or a very strong
loss-of-function allele, as it deletes part of exon 17 plus exons 18–19,
which would induce a premature stop in intron 19, thus truncating all
isoforms (Fig. 3A). All homozygous tm2298 embryos died with a
phenotype indistinguishable from that observed after T17H7.4(RNAi)
(Fig. 3C). Injecting T17H7.4dsRNA into T17H7.4(tm2298)/+mothersdid
not aggravate the phenotype observed for tm2298, which provides
further indication that it is a probable null allele (data not shown).
Looking at the genetic map of chromosome III where T17H7.4 is
located, we noticed two genes with predicted roles in embryonic
morphogenesis and muscle anchoring, pat-4 and pat-12 (Williams and
Waterston, 1994). The gene pat-4 is required for anchoring myoﬁla-
ments to the muscle plasma membrane and encodes the C. elegans ILK
homolog (Mackinnon et al., 2002). The gene pat-12 might also be
involved in anchoring muscles to the epidermis (Williams and Water-
ston, 1994), but its function has not yet been characterizedmolecularly.
Embryos homozygous for pat-12(st430) could elongate until slightly
beyond the two-fold stage; they initially exhibited occasional twitching17H7.4 locus. The positions of pat-12 alleles, or the region targeted for RNAi and of area
uld conﬁrm by RT-PCR. Note that isoforms B and C differ from isoform A by alternative
(B), pat-12(st340) (C), pat-12(tm2298) (D), pat-12(st340)/pat-12(tm2298) (E) embryos.
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(Fig. 3D). To test whether T17H7.4 might correspond to pat-12, we
sequenced the allele pat-12(st430) and tested whether it complements
T17H7.4(tm2298). We found that pat-12(st430) is a G to A transition in
the AG splice acceptor of T17H7.4 exon 14 (Fig. 3A),which should create
a frameshift if exon 14 splicing is skipped. Furthermore, pat-12(st430)
failed to complement T17H7.4(tm2298), producing embryos with a
phenotype intermediate between those induced by st430 and tm2298
alone (Fig. 3E). Consistent with the observation that st430 results in a
phenotype less severe than tm2298, only four of the nine T17H7.4
transcripts thatweconﬁrmed contain exon14.Hence ourmolecular and
genetic data support the conclusion that T17H7.4 corresponds to pat-12.
Belowwewill refer to T17H7.4 as pat-12, as the namewas coined earlier
(Williams and Waterston, 1994).
We found no signiﬁcant PAT-12 homologues outside of the
Nematoda phylum, suggesting that this locus arose in nematodes
only. Among nematodes, many parasitic and free-living species,
including nematodes from clades I, III, IV and V (sequence information
was not available for clade II) contain a pat-12 homologue (Fig. S1).
Conservation is conﬁned to the N-terminal half of the longest isoforms
A, J, and K (Figs. 1 and 3). The different PAT-12 isoforms display no
obvious homology to any known domains according to InterProScan.Distribution of PAT-12A, E, J, K isoforms: PAT-12A and J are ﬁbrous
organelle components
To deﬁne the expression patterns of pat-12 isoforms, we used GFP
translational fusions. Since pat-12 contains four large intronic regionsFig. 4. PAT-12 isoforms associate with hemidesmosomes and ﬁlamentous structures. (A) Sch
the GFP was positioned at the C-terminal of the protein. (B) Summary table of the pattern of e
localization) fusions for the different variant tested. Ph, Pharynx, DV, dorso-ventral, ut, uteru
translational fusions expressed in the wild-type and presented in B. (C, D) Pharynx of an L4 st
of the region highlighted by the dashed rectangle in C. (E, F) A::GFP translational fusion ex
(G) and ABD::mcherry (H) in an embryo showing partial overlap of bothmarkers (I) in the se
with an egg (J) and in the vulva (K) in the adult. Scale bars, 10 μm for C, D, E, F, J and K anbefore the predicted ATG corresponding to isoforms A, K, D, E/F/I, we
assumed that these introns may represent different promoters.
To deﬁne the subcellular localization of PAT-12 isoforms, we used the
immediate upstream intron as a potential promoter to control the
expression of a cDNA (isoforms J, A and K) or genomic DNA (isoform E/F/
I; Fig. 4A).We found that isoforms J andAhadadistributioncharacteristic
of pharyngeal and epidermal FOs, respectively (Fig. 4B–F). Speciﬁcally,
PAT-12J was present at the basal and apical plasma membranes of the
pharynx, like theplakinVAB-10A,whereasPAT-12Aalso colocalizedwith
cIFs in the epidermis, forming parallel bands (Figs. 4B and 5A–B). In
addition, PAT-12J::GFP appeared to be expressed in a punctate manner
that might indicate co-localization with cIFs or aggregation (Fig. 4B–D).
During late stages of embryogenesis, PAT-12K colocalizedwith junctions
between seam and other epidermal cells (not shown) and formed
circumferentially oriented bands in seam cells (Fig. 4B, G). As revealed by
co-expressing PAT-12K::GFP with the actin-binding reporter VAB-
10ABD::mCherry (Gally et al., 2009), this bundle pattern appeared to
partially coincide with actin, although the circumferentially oriented
seam microﬁlament bundles highlighted by mCherry started to fade
away before overlapping the PAT-12K::GFP signal (Fig. 4G-I). Thus, the
nature of the PAT-12K ﬁlaments remains uncertain. In larvae, PAT-12K
distribution was quite similar to that of PAT-12A in the epidermis,
thoughmuch fainter (data not shown). The isoforms PAT-12E/F/I were
detected in the spermatheca, where they marked the plasma
membrane, and veryweakly in the vulva (Fig. 4B, J, K). ). In conclusion,
although PAT-12 expression appears quite complex, our expression
studies support the notion that pat-12 deﬁnes a novel component of
FOs, and raises the possibility that PAT-12 isoforms are present where
cIFs are located.ematic representation of the genomic region used to generate GFP fusions. In each case
xpression of the transcriptional (anatomical localization) and translational (subcellular
s, vul, vulva, mec, mechanosensory, rect, rectum. (C–K) Confocal pictures of the different
age expressing the J::GFP translational fusion. D represents a highmagniﬁcation picture
pressed in embryo (E) or adult (F). (G–I) Coexpression of K::GFP translational fusion
am cells (star in G). (J, K) E::GFP translational fusion expressed in the spermatheca ﬁlled
d 5 μm for G–I.
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To deﬁne whether any isoform is essential for viability, we used
the translational fusion constructs described above to test whether
they could rescue the lethality of the null allele pat-12(tm2298).
Expression of isoforms J, K, or E/F/I could not rescue embryonic
lethality (Fig. 4B). Conversely, expression of isoform A rescued most
pat-12(tm2298) embryos, and a stable homozygous pat-12(tm2298)
mutant transgenic line could be maintained (Fig. 4B). Homozygous
pat-12(tm2298) expressing pat-12A::GFP segregated about 69%
ﬂuorescent animals that could reach adulthood with a growth rate
undistinguishable from the wild-type growth rate (N=154). The
remaining 31% ﬂuorescent embryos developed beyond the three-fold
stage but could not hatch, probably due to mosaic inheritance of the
transgene. This observation shows that the A isoform is essential for
function, and further suggests that PAT-12 function is dispensable for
feeding, fertilization and egg-laying.PAT-12A is essential for ﬁbrous organelle biogenesis
Having established that PAT-12A is a novel ﬁbrous organelle
component, and that it is essential for embryonic morphogenesis, we
wished to assess whether its absence affects ﬁbrous organelle
biogenesis. To do so, we examined pat-12(tm2298) for potential
CeHD and muscle defects.Fig. 5. Differential effect of PAT-12 loss on apical and basal hemidesmosomes. (A, B) Confoca
and L4 larvae showing a perfect overlap of the two colours. (C, E) Confocal pictures after im
heterozygous (C) and pat-12(tm2298) homozygous (E) embryos at the 2-fold stage. C’ and E
and E, respectively. (D, F) Confocal pictures after immunostaining of VAB-10A and IFs(IFs) on
(F) embryos at the 2-fold stage. D’ and F’ represent high magniﬁcations of the region high
possible apical surface of the epidermis. Arrows indicate detached epidermis and muscles. (
Perlecan (I, J) on wild-type (G, I) and pat-12(tm2298) (H, J) 2-fold embryos. G’–J’ represent h
4::GFP localization in a control (K) or pat-12(RNAi) (L) L4 larvae after confocal acquisition.Homozygous pat-12(tm2298) embryos had a normal distribution
of muscles and CeHD components until the two-fold stage, when
muscles start to actively twitch (Fig. S3). Subsequently, muscles
detached from the body wall to collapse centrally, which was
particularly obvious in the head and tail as well as in mid-body where
the bend is more acute (Fig. 5E). Hence, muscles reach their normal
positions, but cannot maintain them once they start to contract, which
suggests that CeHDs are defective.
The distribution of UNC-52/Perlecan, a critical ECM component
betweenmuscles and theepidermis, and LET-805/myotactin, a probable
UNC-52 receptor on the basal side of the epidermis, reﬂected the
positions of muscles (Fig. 5G-J). It was normal until muscles started to
twitch (not shown), and progressively disappeared from the anterior
and posterior tips of the embryo. In the central part of the embryo, they
remained apposed to muscles although LET-805 never formed
characteristic parallel stripes (Fig. 5G-J). The distribution of VAB-10A/
plakin showed the same trend, with two notable differences. First, since
VAB-10A is normally associated with both the basal and apical
membranes, two lines of staining in the same Z-plane could be
transiently observed in pat-12mutants above each muscle quadrant at
the timewhen control embryos reached the two-fold stage.We suggest
that one line corresponds to the basal membrane, and the other to the
apical membrane, suggesting that the epidermis widened and ruptured
internally (Fig. 5E-F). Second, the apical signal became very faint,
implying that it critically depends on PAT-12 for maintenance.
Distribution of intermediate ﬁlaments was also abnormal, as epidermall pictures after immunostaining of PAT-12::GFP and IFs on a wild-type 1.8-fold embryo
munostaining of VAB-10A and body wall muscles on pat-12(tm2298)/sC1[dpy-1(s2170)
’ represent high magniﬁcations of the regions highlighted by the dashed rectangles in C
pat-12(tm2298)/sC1[dpy-1(s2170) heterozygous (D) and pat-12(tm2298) homozygous
lighted by the dashed rectangles in D and F, respectively. Arrowheads point onto the
G–J) Confocal pictures after immunostaining of LET-805/Myotactin (G, H) and UNC-52/
igh magniﬁcations of the region highlighted by the dashed rectangles in G–J. K, L. MUP-
For All panels, scale bars, 10 μm.
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(Fig. 5F), indicating that their integrity or attachment had been broken.
Lastly,we examined thedistributionofMUP-4,whichacts togetherwith
MUA-3 as the putative apical ECMcuticle receptors (Bercher et al., 2001;
Hong et al., 2001). We used pat-12(RNAi) feeding in larvae expressing
MUP-4::GFP (MUP-4::GFP is difﬁcult to see in embryos). We observed
that MUP-4 staining faded away and became blurry in pat-12(RNAi) L4
larvae (Fig. 5L). Consistent with the genetic results described in Fig. 3,
we observed similar, though weaker, defects in pat-12(st430) mutant
embryos (data not shown). We conclude that PAT-12 activity is
important to maintain FO integrity, and, might have distinct functions
apically and basally, based on the differential loss of VAB-10A, cIFs and
ECM receptors at the two plasma membranes.
Rupture of the epidermis and the ensuingmuscle detachment could
primarily result from a detachment of the epidermal plasmamembrane
from the extracellular matrix, or from a loss of FO integrity within the
epidermis. To examine these possibilities, we examined the ultrastruc-
ture of PAT-12 defective animals by electron microscopy. After RNAi
feeding in larvae, we observed a widening of the epidermis in L4 larvae
(Fig. 6A–D) (80±20 nm in control larvae, versus 1.6±.2 μm in pat-12
(RNAi) larvae, N=14). Importantly, the apical plasma membrane was
still associated with the cuticle and the basal plasma membrane still
associated with the basal lamina (Fig. 6C, D). Likewise, in pat-12
(tm2298) embryos that had reached the equivalent of the two-fold
stage, we observed a thickening of the epidermis (average 200 nm in
controls to an average 1.2 μm in pat-12(tm2298) embryos, n=10), yet
plasmamembraneswere still associatedwith the extracellularmatrices
both apically and basally (not shown). Furthermore, the epidermis was
the thickestwhere themuscleswere located, and in several places itwas
sandwiched between muscles forming a spear shape (Fig. 6D). In
conclusion, our EM and immunoﬂuorescence data suggest that
epidermal integrity is lost in pat-12 mutants resulting from internal
rupture, rather than rupture at the level of the plasmamembrane or the
ECM.
PAT-12A localization depends on other ﬁbrous organelle components
One possible interpretation of the results described so far could be
that PAT-12A links VAB-10A to the apical ECM receptor. Alternatively, it
might interact with cIFs and potentially stabilize their interaction withFig. 6. PAT-12 knock-down leads to an epidermolysis bullosa simplex-like phenotype. EM pict
(RNAi) (C, D: highmagniﬁcation of C at the level of the dashedbox) adults showingmuscle and e
on the far right. Arrow (in C), muscle detachment; arrowheads (in B, D), dense bodies. Scale bVAB-10A/plakin, which is the most likely factor capable of anchoring
them at CeHDs (Bosher et al., 2003). Lastly, it could havemore than one
role. A prediction of each scenario is that removing vab-10A or ifb-1
might have different outcomes. For instance, if PAT-12A makes a
complexwithVAB-10Aand IFB-1, loss of eachprotein couldhave similar
consequences on PAT-12A distribution. Alternatively, if PAT-12A
interactswithonlyVAB-10A, lossof cIFswouldnot affect its distribution,
at least initially, until FOs fall apart due to loss of cIFs.
When we removed VAB-10A by RNAi, PAT-12A had a normal
distribution until the 1.5-fold stage. Starting at the 1.8-fold stage, PAT-
12A started to form dim and thin stripes apically in 57% of the animals
(Fig. 7D, D’, n=15). In the remaining 43% of the animals observed,
PAT-12A became fuzzy apically (Fig. 7E, E’, n=9). In all cases, PAT-
12A formed disorganized aggregates basally (Fig. 7E and G). Whenwe
depleted IFB-1 by RNAi in embryos expressing PAT-12A::GFP, we
observed that PAT-12::GFP could form stripes as observed in the vab-
10(RNAi) background. However, these stripes were observed in most
places of the embryo, except in the apical side of the bend past the
two-fold stage (Fig. 7G) and in escaping arrested larvae (Fig. 7H). As a
consequence, VAB-10 depletion had a more severe phenotype with
respect to PAT-12A localisation that IFB-1 did, especially at the apical
side. We conclude that PAT-12A::GFP distribution critically depends
on VAB-10A and to a lesser extent on cIFs.
Discussion
Our studies show that PAT-12 deﬁnes a novel C. elegans
hemidesmosome (CeHD) factor necessary to maintain the two core
CeHD components, the plakin VAB-10A and cytoplasmic intermediate
ﬁlaments (cIFs) (Fig. 8A). In addition, PAT-12 proved to be essential to
maintain the proper distribution of the candidate apically localized
CeHD ECM receptor MUP-4, but not of the candidate basally localized
ECM receptor LET-805 (Fig. 8B).
PAT-12, a new component of the FO
Three lines of evidence strongly support that pat-12 encodes a
novel CeHD component. First, RNAi experiments and genetic analysis
of pat-12mutants, including a presumptive null mutant, showed that
pat-12 is vital for nematode survival, causing paralysis and death inures of wild-type (A, B, high magniﬁcation of A at the level of the dashed box) and pat-12
pidermis structures. The relative positions of each structure are indicated through a legend
ars, 1 μm in low magniﬁcation pictures and 200 nm in high magniﬁcation pictures.
Fig. 7. PAT-12A localization depends on VAB-10A. PAT-12A::GFP localization in wild-type (A, B) vab-10 RNAi-treated (C, D) and ifb-1 RNAi-treated animals (E, F, G). (A, C, E) 1.5-fold
embryos. (B, D, F) Late embryos corresponding to a 3.5-fold stage in wild-type and Pat in RNAi-treated animals. (G) L1 larva corresponding to an escape due to mild ifb-1 RNAi effect.
B’–G’ correspond to high magniﬁcation pictures of the region highlighted with the dashed boxes in B–G. Arrowheads indicate apical surface of the epidermis and arrows point to the
detached basal surface of the epidermis. Efﬁciency of the RNAi was as follows: vab-10(RNAi), 98% embryonic lethal, ifb-1(RNAi), 79% embryonic lethal and 19% larval lethal. For All
panels, scale bars, 10 μm.
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detachment from the body wall in embryos and larvae, a phenotype
typical of CeHD mutants. Second, we found that the PAT-12A isoform
has a characteristic CeHD distribution and colocalizes with epidermal
cIFs. Furthermore, this isoform could rescue the lethality due to the
putative null allele pat-12(tm2298). Third, our characterization of pat-
12 mutants established that the apical and basal epidermal mem-
branes separated from each other, and that several CeHD components
could not be maintained. Electron microscopy (EM) conﬁrmed that
the epidermis adjacent to muscles was enlarged, but did not reveal a
separation at the level of the epidermal plasma membrane. Typically,
loss of the candidate apical CeHD ECM receptors MUP-4 or MUA-3
leads to detachment of the apical plasma membranes from the cuticle
(Bercher et al., 2001; Hong et al., 2001). Similarly, loss of the plakinVAB-10A also increases the distance between the epidermis and the
cuticle (Bosher et al., 2003). Loss of pat-12 thus has a phenotype
consistent with a failure of the cIFs to remain intact and resistant to
stress. In vertebrates, it would qualify as an Epidermolysis Bullosa
Simplex syndrome, rather than as a Junctional Epidermis Bullosa
syndrome (Nievers et al., 1999).
The pat-12 locus encodes several isoforms that are speciﬁcally
expressed in most C. elegans epithelia, including the epidermal seam
cells, the pharynx, the spermatheca, the vulva, the uterus and the
rectum. Despite this widespread expression, our rescue experiments
indicate that expression of PAT-12A,which is only present at the level of
FOs, is sufﬁcient to rescue the embryonic lethality of pat-12(2298) and
generate viable and fertile animals.While it suggests that other isoforms
are not critical for embryonic development and reproduction,we cannot
Fig. 8. Model for PAT-12A localization and function. The schematic drawing shows a transverse apico-basal section through the epidermis and muscle, highlighting the main
hemidesmosome components in wild-type (A) and pat-12 mutants (B). Note that a ﬁbrous organelle corresponds to the apical and basal hemidesmosomes with their
interconnecting intermediate ﬁlaments (cIFs). The question marks in (B) referrers to the potential mislocalization of MUA-3 in pat-12 mutants that we did not test. See text for
further details.
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or stretching forces, perhaps redundantly with other proteins.PAT-12 interaction with VAB-10A and possible molecular function
PAT-12 isoforms do not contain any protein domain that could
provide hints for their role. Nevertheless, the distribution of PAT-12
isoforms, our biochemical analysis and the phenotypes of pat-12
mutants offer indirect clues to their molecular function.
The different pat-12 isoforms appear to have a dual distribution,
since they localize to ﬁlamentous structures like ﬁbrous organelles, but
also to surrounding membranes of the pharynx, rectum, vulva and
epidermis. For example, PAT-12K showed laterally oriented ﬁlaments
that partially coincide with actin microﬁlaments. Two potential and
non-exclusivemechanismsmight account for PAT-12 localization. First,
some or all isoforms could auto-assemble into ﬁlamentous multimers.
Indeed, we did observe a PAT-12–PAT-12 interaction in yeast two-
hybrid tests (data not shown), but we did not attempt to conﬁrm it
biochemically. Alternatively, PAT-12 isoforms could associate with
speciﬁc junctional proteins and/or with other ﬁlamentous proteins. Our
two-hybrid and biochemical data suggest that PAT-12 can interact with
the VAB-10 plakin domain, and our genetic analysis indicates that in the
absence of VAB-10A the distribution of PAT-12A::GFP becomes quite
blurry in the epidermis. Hence, VAB-10 might anchor PAT-12A to
CeHDs. The reports in mass yeast two-hybrid screens that PAT-12 can
interact with four distinct cIFs (Li et al., 2004), which are yet to be
conﬁrmed, and the partial dependence of PAT-12ACeHD localization on
IFB-1 might imply that PAT-12A can also directly associate with cIFs.
However, PAT-12A::GFP maintained a fairly normal distribution in
many places. Furthermore, loss of PAT-12A::GFP localization in some
areas of IFB-1 depleted embryos might be indirect, since IFB-1 is
required to maintain CeHDs (Woo et al., 2004). Hence, we do not
presently favour the idea that PAT-12 localization andpotential function
results from a direct cIF–PAT-12 interaction.In the absence of PAT-12, we observed three main phenotypes:
(i) a progressive loss of VAB-10A from the apical membrane; (ii) a
failure of cIFs to form the typical ﬁbrous organelle repeated stripes
and their apparent separation from the basal membrane; (iii) a
blurry distribution of the putative apical ECM receptor MUP-4, but
not of the putative basal ECM receptor LET-805 (Fig. 8B). Although
CeHD integrity defects appear equally severe in pat-12 and most
other CeHD mutants, the speciﬁc pat-12 cellular phenotypes set it
apart, which helps deﬁne its potential function. For instance, cIFs
aggregate in vab-10A mutants, whereas cIFs and VAB-10A maintain
their banded pattern in vab-19 mutants, although they extend
beyond the muscle adjacent region (Bosher et al., 2003; Ding et al.,
2003) (for a review, see (Zhang and Labouesse, 2010)). Based on
our biochemical data, we propose that apically, PAT-12A presumably
interacts with VAB-10A to maintain apical CeHDs and promote their
assembly into regularly spaced parallel stripes. PAT-12A could
stabilize the potential (and still hypothetical) VAB-10A inter-
action with MUP-4 and MUA-3, or else directly mediate VAB-10A
interaction with MUP-4. The absence of PAT-12A could destabilize
VAB-10A, leading to its loss and to the diffusion of MUP-4 within the
apical plasma membrane. Basally, PAT-12A might also interact with
VAB-10A, but assuming that VAB-10A also interacts with LET-805,
this interaction could be stronger or less dependent on PAT-12A.
Why would cIFs separate from the basal plasma membrane more
readily than from the apical plasma membrane, given that the most
obvious candidate for anchoring cIFs, the plakin VAB-10A (Bosher
et al., 2003), is primarily lost from the apical membrane? First, this
loss is progressive and the interaction between VAB-10A and cIFs
basally might be more labile or might more critically depend on PAT-
12A. Second, MUP-4 and MUA-3 have weak homology in their
cytoplasmic domains with ﬁlaggrin (Hahn and Labouesse, 2001), a
known intermediate ﬁlament binding protein, which might con-
tribute to the retention of cIFs apically when VAB-10A disappears. In
summary, we suggest that PAT-12A acts to stabilize the interaction of
VAB-10A with other proteins.
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A major aim of this project was to characterise pat-12 in order to
assess its suitability as a drug target for parasitic nematodes. To
qualify as an interesting drug target and merit further examination a
number of criteria need to be satisﬁed. First, the target has an essential
function in the relevant nematodes. Highly desirable loss-of-function
phenotypes are lethality, especially in the parasitic stages of the life
cycle, or paralysis, as many parasites once paralysed can be cleared by
the host system, or sterility, which ensures that the next generation is
not produced. PAT-12 is clearly essential in C. elegans, as absence of
pat-12 causes paralysis and lethality, at all stages of development. A
second criterion is that the putative target has broad representation
among relevant parasitic nematodes and good protein homology,
such that a potential anthelmintic drug would potentially affect all
economically important parasites. High protein sequence conserva-
tion maximizes the probability that the orthologous proteins in other
species have a conserved structure that can be ‘blocked’ with a single
drug. PAT-12 certainly appears to fulﬁl this second criterion: highly
conserved PAT-12 homologs were found in most clades, allowing the
O. volvulus antibody OvB20 to recognize a protein with a distribution
very similar to that of PAT-12A. Finally, a potential drug target must
have a ‘druggable’ structure.
Currently drugs are mostly designed by creating or discovering
small molecules that can block the function of receptors or channels or
ﬁt into the binding pockets of enzymes (Behm et al., 2005; Pink et al.,
2005). Although PAT-12 is essential in C. elegans and has orthologues
in parasitic nematodes, it does not possess obvious domains for
binding of small ligands. However, a structural analysis of PAT-12
might reveal domains that can be blocked by small components.
Furthermore, we have established that VAB-10A co-operates with
PAT-12, which is most likely achieved through creation of a complex.
Disrupting this complex, or interfering with the activity of proteins
that regulate the assembly of the putative PAT-12A/VAB-10A
complex, would achieve the same end as blocking PAT-12 function,
and creates a wider pool of possible proteins and pockets to block.
Continued research into the regulation of cIFs and hemidesmosomes
in C. elegans stands to beneﬁt diverse areas of biology.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.11.025.
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